RFK Jr orders mifepristone review as anti-abortion groups push for ban

Health secretary cites ‘new data’ that emerged from flawed study conservatives are using to pressure US government

Susan Rinkunas
Wed 14 May 2025

The US health secretary, Robert F Kennedy Jr, said on Wednesday that he had directed the FDA to review the regulations around the abortion pill mifepristone.

The review, he said, was necessary due to “new data” – data that emerged from a flawed analysis that top US anti-abortion groups are now using to pressure the Trump administration to reimpose restrictions on the abortion pill, if not pull it from the market entirely.

“It’s alarming,” Kennedy told the Missouri senator Josh Hawley, a Republican, during a congressional hearing. “Clearly, it indicates that, at very least, the label should be changed.”

Continued: https://www.theguardian.com/us-news/2025/may/14/rfk-jr-fda-abortion-pill-mifepristone

USA – Where the Conservative War on Abortion Pills Is Headed

By Andrea González-Ramírez, the Cut
March 12, 2025

In his nearly two months in office, President Donald Trump has only made small moves to advance his anti-abortion agenda. But his Justice Department’s decisions to enforce a law that protects abortion clinics from violence only in “extraordinary” cases and to stop defending a Biden-era lawsuit against Idaho that sought to protect access to emergency abortion care in hospitals send a clear signal: The federal government will not defend what curtailed abortion rights remain post-Dobbs. Now, Republican lawmakers emboldened by that message are going after their most urgent target: abortion pills.

Continued: https://www.thecut.com/article/republicans-unleash-new-attacks-on-abortion-pills.html

Access to abortion pills has grown since Dobbs

How activists, clinicians, and businesses are getting abortion medication to all 50 states.

By Rachel M. Cohen
Dec 27, 2023

Eighteen months after the Dobbs v. Jackson decision that overturned the constitutional right to abortion, and with a new Supreme Court challenge pending against the abortion medication mifepristone, confusion abounds about access to reproductive health care in America.

Since the June 2022 decision, abortion rates in states with restrictions have plummeted, and researchers estimated last month that the Dobbs decision led to “approximately 32,000 additional annual births resulting from bans.” Journalists profiled women who carried to term since Dobbs because they couldn’t afford to travel out of their restrictive state.

Continued: https://www.vox.com/policy/2023/12/27/24015092/abortion-pills-mifepristone-roe-reproductive-misoprostol

27.12.2023

Commentary

Abortion Coalition for Telemedicine

abortion pills

abortion support networks

Dobbs v. Jackson Women's Health Organization

Elisa Wells

Expanding Medication Abortion Access

Massachusetts Medication Abortion Access Project

medication abortion

mifepristone

misoprostol

misoprostol only abortions

National Abortion Federation

Plan C

Red State Access

Reproductive Health Initiative for Telehealth Equity and Solutions

self-managed abortion

shield laws

Society of Family Planning

telehealth abortion

telemedicine abortion

USA – Pharmacies begin dispensing abortion pills

A handful of pharmacies are offering the pills 10 months after the Biden administration allowed them to do so.

By ALICE MIRANDA OLLSTEIN and LAUREN GARDNER
Oct 6, 2023

A handful of independent pharmacies across the country have quietly begun dispensing the abortion pill mifepristone under new rules created by the Biden administration earlier this year, even as a looming Supreme Court case could reimpose restrictions or ban the drugs entirely.

Thousands of branches of major pharmacy chains are poised to join them — making the drugs more accessible to millions of people nationwide and kicking off a new phase of the legal and political battle over the most popular method of ending a pregnancy.

Continued: https://www.politico.com/news/2023/10/06/pharmacies-begin-dispensing-abortion-pills-00120397

Abortion rights advocates say consequences dire if U.S. Supreme Court declines to hear pill case

BY: SOFIA RESNICK
OCTOBER 6, 2023

More than a year after the U.S. Supreme Court decided states could set their own abortion laws, including bans, the nation’s highest court now could cut off abortion access in states where abortion is still legal.

The Supreme Court began its new term this week and has yet to announce whether it will hear Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, before the term ends in June 2024. This case was designed by the religious right to overturn the approval of the commonly used abortion drug mifepristone. But whatever the court does — even if it declines to hear the case — will further alter healthcare access in the U.S., reproductive health advocates said on a call to reporters Thursday.

Continued: https://ncnewsline.com/2023/10/06/abortion-rights-advocates-say-consequences-dire-if-u-s-supreme-court-declines-to-hear-pill-case/

A Trump-Stacked Court Hopes to Limit Access to the Abortion Pill. The Final Decision Now Lies With SCOTUS.

8/17/2023
by CARRIE N. BAKER, Ms. Magazine

The Fifth Circuit Court of Appeals released a decision on Wednesday, Aug. 16, that dismissed a challenge to the U.S. Food and Drug Administration’s 2000 approval of mifepristone, but would sharply restrict access to medication abortion nationwide and eliminate telemedicine abortion. The decision in Alliance for Hippocratic Medicine v. FDA remains on hold until final review by the U.S. Supreme Court.

“While the court has acknowledged that mifepristone—both brand and generic versions—can stay on the market, they are insisting we should roll back the clock to 2000 and put the medication under lock and key,” said Kirsten Moore, director of Expanding Medication Abortion Access Project (EMAA Project). “The extremist judges ignored the FDA, our basic rights, and more than 20 years of scientific evidence showing mifepristone is safe and effective, rolling back decades of advancement in the standard of care. This is a dangerous precedent for FDA’s scientific review authority.”

Continued: https://msmagazine.com/2023/08/17/abortion-pills-fifth-circuit-mifepristone/

USA – The Future of Abortion Pills Is on the Line

FEB. 3, 2023
By Andrea González-Ramírez

Since the Supreme Court’s Dobbs decision, abortion pills have been a powerful tool for people to safely end a pregnancy on their own at home in the 14 states that have banned abortion. Abortion opponents and supporters are deeply invested in either cutting off or expanding access to the pills, and that tension has triggered a wave of legal challenges that could determine the future of medication abortion in the U.S.

“Back in the pre-Roe era, abortion was all done via procedure, which meant that if you could control the gatekeepers — the providers — then you could stop abortion in your state or stop a lot of it,” says Greer Donley, an associate professor at the University of Pittsburgh School of Law. “But now pills travel across borders all the time. It makes abortion really hard to control.”

Continued: https://www.thecut.com/2023/02/whats-happening-with-abortion-pills-in-the-courts.html

‘Hot mess’: Abortion pills at pharmacies could face legal quagmires, especially in restrictive states

By Sarah Owermohle
Jan. 19, 2023

WASHINGTON — Federal regulators’ green light for pharmacists to dispense abortion pills is crashing into legal questions and simmering court battles.

The Food and Drug Administration earlier this month removed a longtime restriction that only doctors could dispense mifepristone, which is approved for abortions up to 10 weeks. The move opens the door for pharmacists to supply the drugs and shores up protections for mail orders, which have become an important channel for abortion access in the wake of Roe’s overturn last summer.

Continued: https://www.statnews.com/2023/01/19/abortion-pills-at-pharmacies-legal-quagmires/

This Trump Judge Could Effectively Ban the Abortion Pill

Matthew Kacsmaryk could revoke the FDA's approval of Mifepristone after anti-abortion groups filed a dubious lawsuit in Texas

BY TESSA STUART
JANUARY 18, 2023

THE ALLIANCE FOR Hippocratic Medicine does not have a robust online presence. Its website consists of a generic landing page that appeared in July, a month before the organization was legally incorporated in Amarillo, Texas. There’s no phone number, no email, no physical address, no board of directors listed. A single button, labeled “Learn more about AHM,” just reloads the page. According to records filed with the Texas Secretary of State, the group’s mailing address is located several states away, in Tennessee, but the decision to incorporate in Texas — in Amarillo, specifically — may prove critical in determining the fate of a lawsuit filed in November challenging the Food and Drug Administration’s 22-year approval of Mifepristone, a key component of the abortion pill.

Continued: https://www.rollingstone.com/politics/politics-news/trump-judge-matthew-kacsmaryk-ban-abortion-pill-1234658423/

USA – The new front in the right’s war on abortion

Abortion pills are at the heart of the fight over abortion access in a post-Roe world.

By Rachel M. Cohen
Jan 9, 2023

The Biden administration helped expand access to medication abortion last week, with the US Food and Drug Administration finalizing a rule to make the pills more readily available in pharmacies. But this effort to help patients get pills to end a pregnancy could be dwarfed by a major push to restrict access to the medication from anti-abortion leaders and their Republican allies.

As lawmakers head back to state legislatures this month, many for the first time since Roe v. Wade was overturned in June, Republicans face new pressure to restrict access to the combination of abortion-inducing drugs, mifepristone and misoprostol, used typically within the first 10 to 12 weeks of a pregnancy. Medication abortion has become the most common method for ending pregnancies in the United States, partly due to its safety record, its lower cost, diminished access to in-person care, and greater opportunities for privacy.

Continued: https://www.vox.com/policy-and-politics/2023/1/9/23540562/abortion-pills-medication-dobbs-roe-mifepristone